Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

 
• By Joseph Haas
Radioligand therapeutic
Novartis buys Mariana Oncology to increase its holdings in radioligand therapy • Source: Shutterstock

More from Deals

More from Business